|
A randomized double-blind trial of dextrose-glycerine-phenol injections for chronic, low
back pain. |
|
AUTHORS: |
Klein RG; Eek BC; DeLong WB; Mooney V |
|
AUTHOR AFFILIATION: |
Sansum Medical Clinic, Department of Orthopaedic Medicine, Santa Barbara, CA 93102-1239. |
|
SOURCE: |
J Spinal Disord 1993 Feb;6(1):23-33 |
|
CITATION IDS: |
PMID: 8439713 UI: 93177083 |
|
ABSTRACT: |
This randomized clinical trial evaluated the
efficacy of injections of a dextrose-glycerine-phenol connective tissue
proliferant into the posterior ligaments, fascia, and joint capsules to
treat chronic low back pain. Seventy-nine patients with chronic low back
pain that had failed to respond to previous conservative care were
randomly assigned to receive a double-blind series of six injections at
weekly intervals of either Xylocaine/saline solution or Xylocaine/proliferant
into the posterior sacroiliac and interspinous ligaments, fascia, and
joint capsules of the low back from L4 to the sacrum. Patients were
observed with a visual analog, disability, and pain grid scores, and with
objective computerized triaxial tests of lumbar function
for 6 months following conclusion of injections. Pretreatment imaging
tests with either magnetic resonance imaging (MRI) or computed tomography
(CT) scans were performed in all patients. Thirty of the 39 patients
randomly assigned to the proliferant group achieved a 50% or greater
diminution in pain or disability scores at 6 months compared to 21 of 40
in the group receiving lidocaine (p = 0.042). Subjective parameters
measured at 6 months posttreatment improved (p < 0.001) overall in both
the treatment and control group compared to baseline. Improvements in
visual analog (p =0.056), disability (p = 0.068), and pain grid scores (p
= 0.025) were greater in the proliferant group. Objective testing of range
of motion, isometric strength, and velocity of movement showed significant
improvements in both groups following treatment but did not favor either
group. The MRI and CT scans showed significant abnormalities in both
groups, but these did not correlate with subjective complaints and were
not predictive of response to treatment. |
|
MAIN MESH HEADINGS: |
Glucose/*therapeutic use
Glycerol/*therapeutic use
Low Back Pain/*therapy
Phenols/*therapeutic use
Sclerosing Solutions/*therapeutic use |
|
ADDITIONAL MESH HEADINGS: |
Adult
Biomechanics
Combined Modality Therapy
Double-Blind Method
Drug Combinations
Exercise Therapy
Fascia
Female
Glucose/administration & dosage
Glycerol/administration & dosage
Human
Injections
Ligaments, Articular
Low Back Pain/pathology
Low Back Pain/radiography
Magnetic Resonance Imaging
Male
Middle Age
Pain Measurement
Phenols/administration & dosage
Sclerosing Solutions/administration & dosage
Severity of Illness Index
Support, Non-U.S. Gov't
Tomography, X-Ray Computed
Treatment Outcome |
|
PUBLICATION TYPES: |
CLINICAL TRIAL
JOURNAL ARTICLE
RANDOMIZED CONTROLLED TRIAL |
|
CAS REGISTRY NUMBERS:
|
0 (Drug Combinations)
0 (Phenols)
0 (Sclerosing Solutions)
108-95-2 (Phenol)
50-99-7 (Glucose)
56-81-5 (Glycerol) |